Concepedia

Tangying Lu

TL

Statistics

Publications

11

Citations

2.3K

H-Index

11

Active since

2004

Affiliations

University of South Florida(Current)

National Cancer Institute

National Institutes of Health

Florida College

Kite (United States)

Tangying Lu is an author at University of South Florida specializing in immunology, immunotherapy, and chimeric antigen receptor t-cell therapy.

Publications per year

2004–2017

11

Publications

11

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

Jennifer N. Brudno, Robert Somerville, Victoria Shi et al. · Journal of Clinical Oncology · 2016 · 609 citations · Full text

Life Sciences, Hematology, Immunology +13

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

James N. Kochenderfer, Robert Somerville, Tangying Lu et al. · Journal of Clinical Oncology · 2017 · 561 citations

Medicine, Hematology, Immunology +17

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

Tangying Lu, Rupal Ramakrishnan, Soner Altiok et al. · Journal of Clinical Investigation · 2011 · 361 citations · Full text

Medicine, Immunology, Oncology +17

Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

James N. Kochenderfer, Robert Somerville, Tangying Lu et al. · Molecular Therapy · 2017 · 280 citations · Full text

Medicine, Hematology, Oncology +17

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3

Yong‐Chen Lu, Linda L. Parker, Tangying Lu et al. · Journal of Clinical Oncology · 2017 · 275 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 11